Transdermal Skin Patches Market by Product Type, End Users & Forecast - 2025

1
Product Type - Drug in Adhesive, Matrix,
Reservoir, Vapor Application - Pain Relief,
Nicotine Cessation, Hormone replacement therapy,
Motion Sickness, Neurological Disorders, and
Cardiovascular Disorders Distribution Channel -
Hospital Pharmacies, Retail Pharmacies, and
Online Pharmacies Forecast 2017 - 2025
Transdermal Skin Patches Market
2
Table of Content
Sr. No. Content
Chapter 1 Preface
Chapter 2 Assumptions and Research Methodology
Chapter 3 Executive Summary Global Pulmonary Drug Delivery Devices Market
Chapter 4 Market Overview
Chapter 5 Market Dynamics
Chapter 6 KSA Transdermal Skin Patches Market Analysis, by Product Type
Chapter 7 KSA Transdermal Skin Patches Market Analysis, by Application
Chapter 8 KSA Transdermal Skin Patches Market Analysis, by Distribution Channel
Chapter 9 Company Profiles
3
  Transdermal Skin Patches Market Snapshot

• Transdermal skin patches are medicated patches
  that are attached to the skin which facilitates
  the transfer of drug from the patch into the
  patients body over a period of time.
• Transdermal patches offer several advantages as
  compared to conventional drug delivery methods
  like reduced side effects caused due use of oral
  tablets or pills.
• Transdermal skin patches market based on product
  type, application, distribution channel and
  geography.

4
(No Transcript)
5
Reports Highlights

• Saudi Arabia transdermal skin patches market is
  forecasted to be worth around US 67.41 mn by the
  year 2025 from an earlier valuation of around US
  44.96 mn in the year 2016. During the years of
  forecast that extends from the year 2017 to the
  year 2025, the world market is anticipated to
  rise at a growth rate of 4.7 CAGR.
• Key Players
• Johnson Johnson, Novartis, Teva
  Pharmaceuticals, Mylan, Luye Pharma, Purdue
  Pharma, Hisamitsu Pharmaceutical, and Mundipharma.

Request Sample
6
(No Transcript)